524414 Stock Overview
Norris Medicines Limited engages in the manufacture of injections and medicinal formulations in India.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Norris Medicines Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹14.00 |
| 52 Week High | ₹27.51 |
| 52 Week Low | ₹10.05 |
| Beta | -0.051 |
| 1 Month Change | 4.09% |
| 3 Month Change | -24.53% |
| 1 Year Change | 11.55% |
| 3 Year Change | 50.54% |
| 5 Year Change | 133.33% |
| Change since IPO | 20.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524414 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.8% | -2.8% | -1.5% |
| 1Y | 11.6% | 54.9% | 45.0% |
Return vs Industry: 524414 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 524414 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 524414 volatility | |
|---|---|
| 524414 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524414's share price has been volatile over the past 3 months.
Volatility Over Time: 524414's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 50 | Vimal Shah | www.norrispharma.com |
Norris Medicines Limited engages in the manufacture of injections and medicinal formulations in India. The company offers products in the fields of antibiotic, anti-inflammatory-pain management, anti emetic, nutrition, gastro, cough/cold, skin and allergy, anti-malarial, diabetic, and cardiac, as well as other fields in various formulations, including tablets, capsules, liquid orals, and copical ointments. It also offers contract and loan license manufacturing services.
Norris Medicines Limited Fundamentals Summary
| 524414 fundamental statistics | |
|---|---|
| Market cap | ₹140.01m |
| Earnings (TTM) | -₹19.05m |
| Revenue (TTM) | ₹53.61m |
2.6x
P/S Ratio-7.3x
P/E RatioIs 524414 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524414 income statement (TTM) | |
|---|---|
| Revenue | ₹53.61m |
| Cost of Revenue | ₹23.84m |
| Gross Profit | ₹29.77m |
| Other Expenses | ₹48.82m |
| Earnings | -₹19.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.91 |
| Gross Margin | 55.52% |
| Net Profit Margin | -35.54% |
| Debt/Equity Ratio | -159.1% |
How did 524414 perform over the long term?
See historical performance and comparison